(S)-5-((1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4-(trifluoromethyl)pyridazin-3(2H)-one

99%

Reagent Code: #236363
fingerprint
CAS Number 2381037-82-5

science Other reagents with same CAS 2381037-82-5

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 523.43 g/mol
Formula C₂₀H₂₃F₆N₇O₃
inventory_2 Storage & Handling
Density 1.53±0.1 g/cm3(Predicted)
Storage -20°C

description Product Description

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its high selectivity for JAK1 over other JAK family members may reduce off-target effects and improve safety profiles in long-term therapy. Currently investigated in preclinical and clinical studies for efficacy and pharmacokinetic properties.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 5mg
10-20 days ฿20,600.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
(S)-5-((1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2-yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4-(trifluoromethyl)pyridazin-3(2H)-one
No image available

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its high selectivity for JAK1 over other JAK family members may reduce off-target effects and improve safety profiles in long-term therapy. Currently investigated in preclinical and clinical studies for efficacy and pharmacokinetic properties.

Used in pharmaceutical research as a potent and selective inhibitor of Janus kinase 1 (JAK1), showing promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its high selectivity for JAK1 over other JAK family members may reduce off-target effects and improve safety profiles in long-term therapy. Currently investigated in preclinical and clinical studies for efficacy and pharmacokinetic properties.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...